Chester County News and Community Website
WILMINGTON, DE & MUNICH, Germany — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) and neurocare Group AG have announced a partnership to build a nationwide network of clinics offering integrated neuroplastic care …
A High-Stakes Alliance Aims to Standardize Mental Health Care at Scale Read More
WILMINGTON, DE — The Catholic Diocese of Wilmington is ushering in a new era of leadership in its communications office, with Bishop William E. Koenig appointing Hannah R. Dell as …
New Voice for the Diocese: Hannah Dell Named Wilmington Communications Director Read More
WILMINGTON, DE — RockWallet LLC said it has secured a Money Transmitter License from the State of South Dakota, a regulatory approval that expands the company’s ability to offer digital …
RockWallet Wins Key License, Expands Crypto Access in South Dakota Read More
WILMINGTON, DE — WOUFX LLC has formally launched as a financial markets infrastructure company, built on more than a decade of professional foreign exchange trading experience by its founder, Eshniyozov …
Inside WOUFX: A 13-Year Trading Journey Becomes Market Infrastructure Read More
WILMINGTON, DE — Vasco Electronics is heading into CES 2026 with an expanded slate of AI-driven tools aimed at redefining how people and organizations communicate across languages, unveiling new software …
Vasco Bets Big on AI to Break Language Barriers at CES 2026 Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said it has resubmitted its biologics license application for MOLBREEVI to the U.S. Food and Drug Administration, a key regulatory step toward approval …
FDA Clock Restarts: Savara Refiles MOLBREEVI for Rare Lung Disease Read More
WILMINGTON, DE — A $30 million federal research initiative is taking aim at one of drug development’s most stubborn and costly blind spots: predicting how the human heart will respond …
Virtual Hearts, Real Stakes: $30M ARPA-H Bet Targets Drug Cardiac Risk Read More
WILMINGTON, DE — AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) said their jointly developed breast cancer therapy ENHERTU has received Breakthrough Therapy Designation from the U.S. Food and Drug …
ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook Read More
WILMINGTON, DE — Phreesia (NYSE: PHR) has been named one of The Software Report’s Top 50 Software Companies of 2025, marking its fourth consecutive appearance on the list and its …
Phreesia Cracks Top 10 as Software Recognition Signals Healthcare AI Momentum Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) said it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, placing the biopharmaceutical company in front of …
Incyte Takes JPMorgan Stage as Investors Look for Pipeline Signals Read More